CHAMPIONS ONCOLOGY, INC. Non Peo Neo Avg Total Comp Amt
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Non Peo Neo Avg Total Comp Amt of $388.46 thousand for the 12-month period ending 2026-04-30, per its DEF 14A filed 2026-08-28.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-08-28
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2026-04-30 | $388.46K DEF 14A · filed 2026-08-28 |
| 2025-04-30 | $243.93K DEF 14A · filed 2026-08-28 |
| 2024-04-30 | $803.11K DEF 14A · filed 2026-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |